Lynparza (Olaparib) Capsules


Medical Evidence Lynparza

Generic name : Olaparib.

Trade name : Lynparza.

Manufacturer information :

Lynparza is manufactured by Astra Zeneca Pharmaceuticals LP.

Lynparza FDA Approval :

Lynparza first approved December 19th, 2014.

Lynparza Dosage form :

Capsules: 50 mg.

Lynparza Indications and Usage :

Ovarian Cancer

Indicated as mono therapy for deleterious or suspected deleterious germ line BRA-mutated advanced ovarian cancer in patients who have been treated with ≥3 prior lines of chemotherapy.

Lynparza (Olaparib) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.